Extreme body mass index and survival in newly diagnosed multiple myeloma patients
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Blood cancer journal - 13(2023), 1 vom: 12. Jan., Seite 13 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shah, Urvi A [VerfasserIn] |
---|
Links: |
---|
Themen: |
69G8BD63PP |
---|
Anmerkungen: |
Date Completed 13.01.2023 Date Revised 19.08.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41408-022-00782-7 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351424156 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM351424156 | ||
003 | DE-627 | ||
005 | 20231226051331.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41408-022-00782-7 |2 doi | |
028 | 5 | 2 | |a pubmed24n1171.xml |
035 | |a (DE-627)NLM351424156 | ||
035 | |a (NLM)36631444 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shah, Urvi A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Extreme body mass index and survival in newly diagnosed multiple myeloma patients |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.01.2023 | ||
500 | |a Date Revised 19.08.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Bortezomib |2 NLM | |
650 | 7 | |a 69G8BD63PP |2 NLM | |
700 | 1 | |a Whiting, Karissa |e verfasserin |4 aut | |
700 | 1 | |a Devlin, Sean |e verfasserin |4 aut | |
700 | 1 | |a Ershler, Rachel |e verfasserin |4 aut | |
700 | 1 | |a Kanapuru, Bindu |e verfasserin |4 aut | |
700 | 1 | |a Lee, David J |e verfasserin |4 aut | |
700 | 1 | |a Tahri, Sabrin |e verfasserin |4 aut | |
700 | 1 | |a Gwise, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Rustad, Even H |e verfasserin |4 aut | |
700 | 1 | |a Mailankody, Sham |e verfasserin |4 aut | |
700 | 1 | |a Lesokhin, Alexander M |e verfasserin |4 aut | |
700 | 1 | |a Kazandjian, Dickran |e verfasserin |4 aut | |
700 | 1 | |a Maura, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Auclair, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Birmann, Brenda M |e verfasserin |4 aut | |
700 | 1 | |a Usmani, Saad Z |e verfasserin |4 aut | |
700 | 1 | |a Gormley, Nicole |e verfasserin |4 aut | |
700 | 1 | |a Marinac, Catherine R |e verfasserin |4 aut | |
700 | 1 | |a Landgren, Ola |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Blood cancer journal |d 2011 |g 13(2023), 1 vom: 12. Jan., Seite 13 |w (DE-627)NLM219701628 |x 2044-5385 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:12 |g month:01 |g pages:13 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41408-022-00782-7 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2023 |e 1 |b 12 |c 01 |h 13 |